Cardinal Health Financial Statements (CAH)
|
|
|
|
Report date
|
|
|
11.08.2022 |
15.08.2023 |
14.08.2024 |
12.08.2025 |
11.08.2026 |
|
30.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
181 326 |
204 979 |
226 827 |
222 578 |
254 248 |
|
250 549 |
|
Operating Income, bln rub |
|
|
-607.0 |
752.0 |
1 243 |
2 275 |
2 613 |
|
2 312 |
|
EBITDA, bln rub |
? |
|
55.0 |
1 439 |
1 962 |
3 106 |
3 478 |
|
3 042 |
|
Net profit, bln rub |
? |
|
-938.0 |
330.0 |
852.0 |
1 561 |
1 714 |
|
1 559 |
|
|
OCF, bln rub |
? |
|
3 122 |
2 844 |
3 762 |
2 397 |
5 174 |
|
5 009 |
|
CAPEX, bln rub |
? |
|
387.0 |
481.0 |
511.0 |
547.0 |
649.0 |
|
617.0 |
|
FCF, bln rub |
? |
|
2 735 |
2 363 |
3 251 |
1 850 |
4 525 |
|
4 392 |
|
Dividend payout, bln rub
|
|
|
559.0 |
525.0 |
499.0 |
494.0 |
491.0 |
|
491.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
159.1% |
58.6% |
31.6% |
28.6% |
|
31.5% |
|
|
OPEX, bln rub |
|
|
7 091 |
6 122 |
6 171 |
5 893 |
7 161 |
|
6 918 |
|
Cost of production, bln rub |
|
|
174 842 |
198 105 |
219 413 |
214 410 |
244 474 |
|
241 319 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
147.0 |
84.0 |
51.0 |
215.0 |
348.0 |
|
343.0 |
|
|
Assets, bln rub |
|
|
43 878 |
43 349 |
45 121 |
53 122 |
57 299 |
|
56 689 |
|
Net Assets, bln rub |
? |
|
-709.0 |
-2 958 |
-3 213 |
-2 781 |
-2 883 |
|
-2 832 |
|
Debt, bln rub |
|
|
5 805 |
5 176 |
5 609 |
9 345 |
9 948 |
|
8 916 |
|
Cash, bln rub |
|
|
4 717 |
4 076 |
5 133 |
3 874 |
4 856 |
|
3 937 |
|
Net debt, bln rub |
|
|
1 088 |
1 100 |
476.0 |
5 471 |
5 092 |
|
4 979 |
|
|
Ordinary share price, rub |
|
|
52.3 |
94.6 |
|
168.0 |
237.6 |
|
221.8 |
|
Number of ordinary shares, mln |
|
|
279.0 |
261.0 |
245.0 |
241.0 |
236.0 |
|
235.0 |
|
|
Market cap, bln rub |
|
|
14 583 |
24 683 |
0 |
40 488 |
56 064 |
|
52 123 |
|
EV, bln rub |
? |
|
15 671 |
25 783 |
476 |
45 959 |
61 156 |
|
57 102 |
|
Book value, bln rub |
|
|
-8 338 |
-9 043 |
-9 663 |
-14 958 |
-16 514 |
|
-16 530 |
|
|
EPS, rub |
? |
|
-3.36 |
1.26 |
3.48 |
6.48 |
7.26 |
|
6.63 |
|
FCF/share, rub |
|
|
9.80 |
9.05 |
13.3 |
7.68 |
19.2 |
|
18.7 |
|
BV/share, rub |
|
|
-29.9 |
-34.6 |
-39.4 |
-62.1 |
-70.0 |
|
-70.3 |
|
|
EBITDA margin, % |
? |
|
0.03% |
0.70% |
0.86% |
1.40% |
1.37% |
|
1.21% |
|
Net margin, % |
? |
|
-0.52% |
0.16% |
0.38% |
0.70% |
0.67% |
|
0.62% |
|
FCF yield, % |
? |
|
18.8% |
9.57% |
|
4.57% |
8.07% |
|
8.43% |
|
ROE, % |
? |
|
132.3% |
-11.2% |
-26.5% |
-56.1% |
-59.5% |
|
-55.0% |
|
ROA, % |
? |
|
-2.14% |
0.76% |
1.89% |
2.94% |
2.99% |
|
2.75% |
|
|
P/E |
? |
|
-15.5 |
74.8 |
0.00 |
25.9 |
32.7 |
|
33.4 |
|
P/FCF |
|
|
5.33 |
10.4 |
0.00 |
21.9 |
12.4 |
|
11.9 |
|
P/S |
? |
|
0.08 |
0.12 |
0.00 |
0.18 |
0.22 |
|
0.21 |
|
P/BV |
? |
|
-1.75 |
-2.73 |
0.00 |
-2.71 |
-3.39 |
|
-3.15 |
|
EV/EBITDA |
? |
|
284.9 |
17.9 |
0.24 |
14.8 |
17.6 |
|
18.8 |
|
Debt/EBITDA |
|
|
19.8 |
0.76 |
0.24 |
1.76 |
1.46 |
|
1.64 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.21% |
0.23% |
0.23% |
0.25% |
0.26% |
|
0.25% |
|
| Cardinal Health shareholders |
